Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
By upregulating VEGFR2 signaling, the compound promotes the formation of new blood vessels in damaged tissue a process called angiogenesis
Report new vision changes, severe weakness, or swelling promptly
Qualifications vary by state, but key indicators of a legitimate operation include: a named medical director who actively oversees clinical protocols, licensed nursing or medical staff performing injections, a thorough intake process that includes health history and allergy screening, and compliance with state Board of Medicine regulations regarding injectable treatments
PubChem Compound Summary for CID 9941957
As of 2026, neither compound has FDA approval, limiting prescribing to research contexts or off-label use by physicians specializing in obesity medicine or endocrinology
Available: [2] PubChem, Bpc-157
US$ 21.67
US$ 20.43
US$ 26.80
US$ 23.08
